Showing 2621-2630 of 7247 results for "".
Legalities of Injecting PDGF: Off-Label or Out-of-Bounds?
https://practicaldermatology.com/issues/october-2025/legalities-of-injecting-pdgf-off-label-or-out-of-bounds/39754/In medicine, science often moves faster than the rules designed to contain it do, and few debates illustrate this tension as starkly as the current one surrounding platelet-derived growth factor (PDGF) injections in aesthetic medicine.The Dermatology Market: A Tidal Wave of Private Equity Investment
https://practicaldermatology.com/topics/practice-management/the-dermatology-market-a-tidal-wave-of-private-equity-investment/20416/A beginner's guide to the complex world of mergers and acquisitions.Update On the Use of Spironolactone to Treat Adult Female Acne
https://practicaldermatology.com/topics/general-topics/update-on-the-use-of-spironolactone-to-treat-adult-female-acne/20917/There is a role for spironolactone in some adult female acne patients.Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.The Road to Denver – Targeting IL-31: A Case-Based Journey
https://practicaldermatology.com/series/nemluvio-peer-network/the-road-to-denver-targeting-il-31-a-case-based-journey/56419/Join Dr Raj Chovatiya, Dr Mona Shahriari, and Dr Jonathan Silverberg as they discuss Targeting the IL-31 Neuroimmune Pathway: A Case-Based Approach. This Product Theater will take place Sunday, March 29, 2026, from 10:30–11:15 AM MT at the Colorado Convention Center, Theater 1 in Denver, Colorado. PRoflumilast Cream, 0.15%, for Atopic Dermatitis
https://practicaldermatology.com/issues/december-2024/Roflumilast-Cream-Atopic-Dermatitis/32840/Atopic dermatitis (AD) is a chronic, persistent inflammatory condition that significantly disrupts the quality of life of patients diagnosed with it. Moreover, AD presents challenges for clinicians when counseling patients on the management of their condition. Application frequency, treatment formulIsotretinoin Insights: Patient Counseling
https://practicaldermatology.com/topics/practice-management/isotretinoin-insights-patient-counseling/21179/A panel of acne specialists discusses their approach to prescribing isotretinoin, in follow-up to last month's overview of isotretinoin in practice.Evaluation and Management of Melanocytic Nevi in Children
https://practicaldermatology.com/topics/general-topics/evaluation-and-management-of-melanocytic-nevi-in-children/21570/Children with melanocytic nevi require proper counseling to discuss the risk for melanoma.Dermal Micro-Coring 101
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dermal-micro-coring-101/23376/Expert insight on a new energy-free facelift alternative.Residents' Reports: A Comparison of Fractional Resurfacing Lasers
https://practicaldermatology.com/topics/general-topics/residents-reports-a-comparison-of-fractional-resurfacing-lasers/21966/Practitioners considering an investment in resurfacing lasers may benefit from this comparison of key system features.